Looking to publish in Alzheimers & Dementia-Translational Research & Clinical Interventions? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowAlzheimer's & Dementia: Translational Research & Clinical Interventions (TRCI) is an open access journal that seeks to bridge drug discovery research and clinical studies for dementia and Alzheimer's disease. It publishes preclinical and clinical translational research, including disease biology, therapeutic development, observational and interventional human studies, precision medicine approaches, clinical trial design and outcomes, and related health economics focused on therapeutic development and treatment.
Looking to publish in Alzheimers & Dementia-Translational Research & Clinical Interventions? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Alzheimers & Dementia-Translational Research & Clinical Interventions accepts the following article types. Click on an article type to view submission instructions.
Review Articles
Systematic Reviews
Meta-Analyses
Narrative Reviews
Research Articles
Short Reports
Letters To The Editor
Recent Publications
Reframing Alzheimer's disease as a complex adaptive system: More than an amyloid beta–tau connection
Maurizio Giorelli
Single‐subject proteomic signatures in Alzheimer's disease reflect clinical phenotypes and distinguish asymptomatic from symptomatic cases
Avijit Podder, Yi Juin Liew, Gregory A. Cary, Gregory W. Carter, Asli Uyar
The utility of a composite endpoint for tracking disease progression in Lewy body dementia
Elie Matar, Simon R. White, John‐Paul Taylor, Alan Thomas, Ian McKeith, Joseph Kane, Simon Lewis, Ajenthan Surendranathan, John O'Brien
Worth their weight in gray matter? A narrative review of cost‐effectiveness analyses of monoclonal antibodies for Alzheimer's disease
Tuyet Thao Nguyen, Bozhidar T. Chakalov, Megan Van Noord, Charles DeCarli, Jeffrey S. Hoch
Economic evaluations of strategies targeting pre‐diagnosis dementia populations: A systematic review
Men Thi Hoang, Alina Mona Zenker, Sanjib Saha, Ulf‐Göran Gerdtham, Dominic Trépel
Frequently asked questions
How long does it take to publish?
Median submission to first decision is 19 days, median submission to acceptance is 104 days, and median acceptance to publication is 36 days.
Reformat to Alzheimers & Dementia-Translational Research & Clinical Interventions using Livewrite PremiumIs a cover letter required?
A submission letter should include the names, mailing addresses, phone and fax numbers, and e-mail addresses of 5-7 potential reviewers with appropriate expertise.
Reformat to Alzheimers & Dementia-Translational Research & Clinical Interventions using Livewrite PremiumWhat are the publication costs?
The journal operates an open access model and does not charge submission fees. APCs apply, with a 50% discount for ISTAART members and additional waivers and discounts for eligible authors in developing countries.
Reformat to Alzheimers & Dementia-Translational Research & Clinical Interventions using Livewrite Premium